Real‐world implementation of DPYD and UGT1A1 pharmacogenetic testing in a community‐based cancer center

Documenti analoghi

• Uptake of DPYD and UGT1A1 testing in Italy and adherence to pharmacogenetic guidelines: A 5‐year perspective from an EQA provider
  di: Rossana Roncato, et al.
  Pubblicazione: (2025)
• A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice
  di: Teresa T. Ho, et al.
  Pubblicazione: (2025)
• Global Investigation of Clinical Implementation Strategies for DPYD Testing to Guide Fluoropyrimidine Therapy
  di: Nihal El Rouby, et al.
  Pubblicazione: (2025)
• La Unión Europea ampliada estudia sus opciones constitucionales / Arielle Rouby
  di: Rouby, Arielle
  Pubblicazione: (2004)
• The role of DPYD and the effects of DPYD suppressor luteolin combined with 5‐FU in pancreatic cancer
  di: Hiroyuki Kato, et al.
  Pubblicazione: (2024)